Position in ABSI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$898,456
+$665,896 QoQ
Shares Held
77,520
0.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 195 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KING LUTHER CAPITAL MANAGEMENT CORP holds $11,681,102 across 6 Biotechnology names. ABSI ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
67,333 | $5,270,153 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
53,725 | $4,379,124 | |
| 3 | ABSI |
Absci Corp
This page
|
77,520 | $898,456 | |
| 4 | MNKD |
Mannkind Corp
|
138,605 | $590,457 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
800 | $498,832 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
58,000 | $44,080 |
All Filings in ABSI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $898,456 | 77,520 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $232,560 | 77,520 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $270,544 | 77,520 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $235,660 | 77,520 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $199,226 | 77,520 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $194,575 | 77,520 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $203,102 | 77,520 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $296,126 | 77,520 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||